Alums Jacob Becraft PhD ’19 and Tasuku Kitada founded Strand Therapeutics to move research from the Weiss and Irvine Labs into the clinic, developing mRNA medicines to engage the immune system against cancer. With the company now in mid-stage trials, Becraft discusses strengths of MIT’s support for entrepreneurship with President Kornbluth at MIT Sandbox’s anniversary celebration.